Soliris and Red cell distribution width increased - a phase IV clinical study of FDA data
Summary:
Red cell distribution width increased is reported as a side effect among people who take Soliris (eculizumab), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Exjade, and have Paroxysmal nocturnal haemoglobinuria.
The phase IV clinical study analyzes which people have Red cell distribution width increased when taking Soliris. It is created by eHealthMe based on reports of 58,774 people who have side effects when taking Soliris from the FDA, and is updated regularly.
What is Soliris?
Soliris has active ingredients of eculizumab. It is often used in paroxysmal nocturnal hemoglobinuria (pnh). eHealthMe is studying from 58,821 Soliris users. Check the latest studies of Soliris.
What is Red cell distribution width increased?
Red cell distribution width increased is found to be associated with 607 drugs and 653 conditions by eHealthMe. Check the latest studies of Red cell distribution width increased.
58,774 people reported to have side effects when taking Soliris.
Among them, 133 people (0.23%) have Red cell distribution width increased.
Among these 133 people:
How long have people been on Soliris when they have Red cell distribution width increased? *
What is the gender of people who have Red cell distribution width increased when taking Soliris? *
What is the age of people who have Red cell distribution width increased when taking Soliris? *
What are other drugs people take besides Soliris? *
What are other side effects people have besides Red cell distribution width increased? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Soliris and have Red cell distribution width increased?
- Check whether Red cell distribution width increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Soliris:
- Soliris (58,821 reports)
Red cell distribution width increased treatments and more:
- Red cell distribution width increased (5,525 reports)
How severe was Red cell distribution width increased and when was it recovered:
Expand to all the drugs that have ingredients of eculizumab:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Soliris:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Red cell distribution width increased:
- Red cell distribution width increased (607 drugs)
Browse all the conditions that are associated with Red cell distribution width increased:
- Red cell distribution width increased (653 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on eculizumab (the active ingredients of Soliris) and Soliris (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Sleep Disorder and Hot Flush - now
- Sensory Disturbance and drugs of ingredients of fentanyl citrate - a second ago
- Could Rezulin cause Ear Disorder? - 4 seconds ago
- Tracleer and Localised Infection for Men aged 60+ - 5 seconds ago
- Could Hydramine cause Pulmonary Embolism? - 5 seconds ago
- Tradjenta and Pepcid drug interactions for men aged 60+ - 6 seconds ago
- Could Fentanyl-100 cause Urinary Incontinence Aggravated? - 6 seconds ago
- Could Klor-Con cause Pulmonary Oedema Aggravated? - 8 seconds ago
- Ciprofloxacin and Sitagliptin drug interactions for women aged 60+ - 10 seconds ago
- Could Albuterol cause Actinic Keratosis? - 14 seconds ago